Daniel E. Stepan

3.9k citations
34 papers · 3.0k · 4 hit papers · h-index 17

Impact in

Papers in

Daniel E. Stepan

34 papers receiving 2.9k citations

Daniel E. Stepan's Hit Papers

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors 2020 · 315 citations
3150+7+14Years since publication100200300400500

Peers

Daniel E. Stepan
Comparison fields: 5 of 90
  • Obstetrics and Gynecology 297
  • Oncology 1.0k
  • Endocrinology, Diabetes and Metabolism 549
  • Reproductive Medicine 251
  • Infectious Diseases 534
Replace Mohammed Akhtar with:
Mohammed Akhtar Saudi Arabia
Dorothy L. Rosenthal United States
Claire W. Michael United States
Catherine Lhommé France
Kuniyuki Oka Japan
Antonietta D’Errico Italy
Roland E. Knoblauch United States
Harry J. Long United States
Vincent Molinié France
Nicole Massoll United States
Daniel E. Stepan relative to Mohammed Akhtar Saudi Arabia Mohammed Akhtar's profile →
Citations per field
00.5×5.6×
Mohammed Akhtar · 1×
Citations per year

Countries citing papers authored by Daniel E. Stepan

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Stepan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Stepan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Stepan more than expected).

Fields of papers citing papers by Daniel E. Stepan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Stepan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Stepan. The network helps show where Daniel E. Stepan may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel E. Stepan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel E. Stepan Line = papers co-authored together Daniel E. Stepan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation
Hit paper breakdown →
2004585
2 2008387
3
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Hit paper breakdown →
2020369
4
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Hit paper breakdown →
2019368
5
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
Hit paper breakdown →
2020315
6 2009281
7 2011185
8 200385
9 199869
10
Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies.
198453
11 201050
12 201837
13 201135
14 201829
15 201726
16 201722
17 200717
18 200616
19 201810
20 20199

About Daniel E. Stepan

Daniel E. Stepan is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Reproductive Medicine, having authored 34 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Renal cell carcinoma treatment (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Endometriosis Research and Treatment (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Obstetrics and Gynecology (297 citations), Oncology (1.0k citations), Endocrinology, Diabetes and Metabolism (549 citations), Reproductive Medicine (251 citations) and Infectious Diseases (534 citations). Daniel E. Stepan has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Matthew H. Taylor, Corina E. Dutcus, Vicky Makker, Robert Shumaker, Drew Rasco, Yu-Nien Sun, Emmett V. Schmidt, Lori J. Wirth, Jane Wu and Martin Schlumberger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Clinical Infectious Diseases and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact